The global Carnitine market experienced a significant price increase in February 2025 due to several key market influences. Rising demand from the nutraceutical and healthcare industries, combined with constrained supply, created strong market pressures that drove prices higher.

The 15-day Lunar New Year holiday period in China from January 29 to February 12 caused manufacturing delays because businesses either stopped production or worked with reduced capacity. Extended time off work, combined with inefficient supply chain management, resulted in industrial delays in the manufacturing and distribution of Carnitine and other nutraceuticals.

The available stockpiles of suppliers and producers decreased substantially during the weeks before the holiday to fulfill pre-holiday demand, which caused Carnitine inventory levels to decrease substantially. The resumption of manufacturing activities across February created a supply-demand mismatch which led to Carnitine price increases.

President Donald Trump implemented a 10 percent tariff on Chinese imports through executive order on February 1, 2025, which worsened market situation. The United States obtains most of its Carnitine supply from China so nutraceutical companies that depend on Chinese imports experienced higher procurement expenses. The added costs were transferred to both customers and end users through price increases.

China's strategic actions against U.S. tariffs created substantial changes in the European market. The 10% tariff transformed the United States into a less desirable export market which led Chinese producers to redirect their exports toward Europe for volume maintenance. The supply chain became more stable through this strategic move, but the Lunar New Year production slowdown created new market uncertainties. European Carnitine buyers raised their purchasing levels which led to increased market competition and rising prices.

The volatile market conditions will drive global Carnitine prices upward because key regions maintain strong demand. Due to supply chain disruptions, changes in trading relationships, and fierce competition for the few available stocks, the market is showing an upward trend.  Additional obstacles to the stability of carnitine prices arise from the execution of Trump's plans, which may increase tariffs on imports from China.

Prices for carnitine may rise as a result of the Indian government's support of the nutraceuticals industry through export and procurement assistance programs.  It is anticipated that these actions will strengthen export capacities, simplify regulations, and improve infrastructure, which will ultimately increase commerce and output. The rising international demand for nutraceuticals including Carnitine will drive Indian manufacturers to expand their production capacity to fulfill this expanding market need. The combination of rising production levels and elevated procurement expenses from supply chain modifications and heightened material competition will drive Carnitine price increases.